Cubist Systematic Strategies, LLC Tandem Diabetes Care Inc Call Options Transaction History

Cubist Systematic Strategies, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$30.43 - $53.43 $1.26 Million - $2.21 Million	-41,400 Reduced 77.09%	12,300 $495,000
Q1 2024 May 15, 2024	BUY	$22.09 - $35.41 $247,408 - $396,591	11,200 Added 26.35%	53,700 $1.9 Million
Q4 2023 Feb 14, 2024	BUY	$14.28 - $31.03 $65,688 - $142,738	4,600 Added 12.14%	42,500 $1.26 Million
Q3 2023 Nov 14, 2023	BUY	$19.33 - $36.22 $523,842 - $981,562	27,100 Added 250.93%	37,900 $787,000
Q2 2023 Aug 14, 2023	BUY	$24.18 - $42.46 $50,778 - $89,166	2,100 Added 24.14%	10,800 $265,000
Q1 2023 May 15, 2023	SELL	$35.86 - $46.5 $46,618 - $60,450	-1,300 Reduced 13.0%	8,700 $353,000
Q4 2022 Feb 14, 2023	BUY	$35.49 - $56.15 $99,372 - $157,220	2,800 Added 38.89%	10,000 $449,000
Q3 2022 Nov 14, 2022	BUY	$43.76 - $68.97 $315,072 - $496,584	7,200 New	7,200 $345,000

344

72.7M

3.12M

343K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.83B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.